Skip to main content

Advertisement

Log in

Bringing antivenoms to Sub-Saharan Africa

  • Commentary
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

To reduce unacceptably high death rates from snakebite envenomation, sub-Saharan Africa must adopt not only a new generation of multivalent biotech antivenoms, but also an infrastructure to deliver them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

References

  1. Chippaux, J-P. Venins de Serpent et Envenimations (IRD Editions, Col. Didactiques, Paris, 2002).

    Book  Google Scholar 

  2. Gutiérrez, J.M., Theakston, R.D.G. & Warrell, D.A. PLoS Med. 3, 727–731 (2006)

    Article  Google Scholar 

  3. Chippaux, J-P. Toxicon 36, 1503–1506 (1998).

    Article  CAS  Google Scholar 

  4. Chippaux, J-P. in Perspectives in Molecular Toxinology (ed. Ménez, A.) 457–472 (Wiley & Sons, London, 2002).

    Google Scholar 

  5. Lalloo, D.G. & Theakston, R.D.G. J. Toxicol. Clin. Toxicol. 41, 277–290 (2003).

    Article  CAS  Google Scholar 

  6. Chippaux, J.P. Bull. Soc. Pathol. Exot. 98, 263–268 (2005).

    CAS  PubMed  Google Scholar 

  7. Theakston, R.D.G., Warrell, D.A. & Griffiths, E. Toxicon 41, 541–557 (2003).

    Article  CAS  Google Scholar 

  8. Chippaux, J.P., Stock, R.P. & Alagón, A. Toxicon 46, 115–118 (2005).

    Article  CAS  Google Scholar 

  9. Chippaux, J.P., Lang, J., Amadi-Eddine, S., Fagot, P. & Le Mener, V. Am. J. Trop. Med. Hyg. 61, 1017–1018 (1999).

    Article  CAS  Google Scholar 

  10. Nkinin, S.W. et al. Bull. Soc. Pathol. Exot. 90, 277–281 (1997).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Many people have contributed to this initiative and continue to do so. From the Republic of Benin, we wish to warmly acknowledge the absolutely essential work of all the health personnel involved in the ongoing clinical trials. From the Instituto Bioclon (Mexico City), the makers of Africamyn, for their consistent support in every imaginable way: J. López de Silanes, J. Paniagua-Solís, J. Estévez and others; from the Instituto de Biotecnología, B. Ramos-Cerrillo and Adolfo de Roodt. From Latoxan (France), Y. Doljansky and F. Principaud. And to all the participants at the 2ème Colloque sur les envenimations en Afrique, Cotonou, 2004, who have contributed, and continue to contribute, invaluable epidemiological data for quite a few West and Central African countries.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

We have a research grant from Instituto Biolclon, S.A. de C.V. (a Mexican producer of antivenoms for developing snake antivenom to be used in Africa. R.P.S. and A.A. also receive consultation fees from Bioclon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stock, R., Massougbodji, A., Alagón, A. et al. Bringing antivenoms to Sub-Saharan Africa. Nat Biotechnol 25, 173–177 (2007). https://doi.org/10.1038/nbt0207-173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0207-173

  • Springer Nature America, Inc.

This article is cited by

Navigation